Synergistic Killing of Streptococcus pneumoniae with the Bacteriophage Lytic Enzyme Cpl-1 and Penicillin or Gentamicin Depends on the Level of Penicillin Resistance

This publication has 11 references indexed in Scilit:

• Phage lytic enzymes as therapy for antibiotic-resistant Streptococcus pneumoniae infection in a murine sepsis model
  Journal of Antimicrobial Chemotherapy, 2003
• Phage Lytic Enzyme Cpl-1 as a Novel Antimicrobial for Pneumococcal Bacteremia
  Infection and Immunity, 2003
• Synergistic Lethal Effect of a Combination of Phage Lytic Enzymes with Different Activities on Penicillin-Sensitive and -Resistant Streptococcus pneumoniae Strains
  Antimicrobial Agents and Chemotherapy, 2003
• A bacteriolytic agent that detects and kills Bacillus anthracis
  Nature, 2002
• Rapid Killing of Streptococcus pneumoniae with a Bacteriophage Cell Wall Hydrolase
  Science, 2001
• The Role of murMN Operon in Penicillin Resistance and Antibiotic Tolerance of Streptococcus pneumoniae
  Microbial Drug Resistance, 2001
• Prevention and elimination of upper respiratory colonization of mice by group A streptococci by using a bacteriophage lytic enzyme
  Proceedings of the National Academy of Sciences, 2001
• Carriage of Internationally Spread Clones ofStreptococcus pneumoniaewith Unusual Drug Resistance Patterns in Children Attending Day Care Centers in Lisbon, Portugal
  The Journal of Infectious Diseases, 2000
• Bacteriophages of Streptococcus pneumoniae: A Molecular Approach
  Microbial Drug Resistance, 1997
• Penicillin Tolerance in Multiply Drug-Resistant Natural Isolates of Streptococcus pneumoniae
  The Journal of Infectious Diseases, 1985